bladder squamous cell carcinoma (Cancer)
Information
- Disease name
- bladder squamous cell carcinoma
- Disease ID
- DOID:3742
- Description
- "A carcinoma of bladder that is manifested in squamous cells of the bladder." [url:http\://www.cancer.gov/cancertopics/types/bladder]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02496208 | Active, not recruiting | Phase 1 | Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors | July 22, 2015 | September 30, 2024 |
| NCT03866382 | Recruiting | Phase 2 | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors | May 13, 2019 | February 28, 2025 |
| NCT05756569 | Recruiting | Phase 2 | Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology | September 26, 2023 | December 16, 2027 |
| NCT00072137 | Terminated | Phase 1 | Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy | October 2003 | November 2010 |
| NCT03912818 | Terminated | Phase 2 | Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer | April 10, 2019 | August 11, 2022 |
- Disase is a (Disease Ontology)
- DOID:4007
- Cross Reference ID (Disease Ontology)
- NCI:C4031
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:255111004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0279681
- Exact Synonym (Disease Ontology)
- Epidermoid carcinoma of the urinary bladder
- Exact Synonym (Disease Ontology)
- squamous cell carcinoma of bladder